Drug intelligence / Profile preview

α-FABP2 antibody

Development stage
Unknown
Modality
Antibody-Based Therapeutics
Administration
Intravenous, Intraperitoneal
01

Overview

α-FABP2 antibody (anti-fatty acid-binding protein 2 antibody) is a research-grade antibody designed to target and neutralize fatty acid-binding protein 2 (FABP2, also known as intestinal fatty acid-binding protein or I-FABP). In preclinical models of Crohn's disease and enteritis, treatment with α-FABP2 antibody has been shown to mitigate gut dysbiosis and alleviate intestinal inflammation. This therapeutic effect is achieved by blocking the interaction between host-derived FABP2 and commensal bacteria such as *Enterococcus faecalis*, which otherwise hijacks FABP2 via the pheromone-binding protein EF3041 to activate quorum-sensing pathways and promote bacterial proliferation.

Other names
alpha-FABP2 antibodyalpha-FABP-2 antibodyalpha-FABP 2 antibodyanti-FABP2 antibodyanti-FABP-2 antibodyanti-FABP 2 antibodyanti-fatty acid-binding protein 2 antibodyanti-intestinal fatty acid-binding protein antibody
02

Targets

ABC family (ATP-binding cassette transporter family)FABP (Fatty acid-binding protein family)

Beyond the preview

Go deeper on α-FABP2 antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α-FABP2 antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call